Wj. Adams et al., CIMETIDINE INHIBITS IN-VIVO GROWTH OF HUMAN COLON-CANCER AND REVERSESHISTAMINE-STIMULATED IN-VITRO AND IN-VIVO GROWTH, Gut, 35(11), 1994, pp. 1632-1636
The effect of histamine and cimetidine on the growth of four human col
on cancer cell lines was studied. Histamine significantly stimulated t
he uptake of tritiated thymidine in vitro in a dose dependent manner,
to a maximum of 120% and 116% of controls for C170 and LIM2412, respec
tively. This effect was antagonised by cimetidine, but not diphenhydra
mine. Histamine also stimulated a dose dependent increase in cyclic ad
enosine monophosphate accumulation in C170 cells, antagonised by cimet
idine. When grown as subcutaneous xenografts in Balb/c nu/nu mice, cim
etidine had a significant inhibitory effect on the same two cell lines
. The final volume of C170 tumours in animals given cimetidine was 44%
of controls. This response was dose dependent, plateauing at a cimeti
dine dose of 50 mg/kg/day. The final volume of LIM2412 tumours in anim
als given cimetidine was 60% of controls. Histamine administered local
ly by a mini-osmotic pump stimulated C170 tumour growth to 164% of con
trols, was antagonised by cimetidine at a dose of 200 mg/kg/day, but n
ot by lower concentrations. Histamine has a trophic effect on at least
two colorectal cancer cell lines in vivo and in vitro. As this effect
is antagonised by cimetidine, it may be mediated via tumour histamine
type 2 receptors.